Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
startups
6
×
life sciences
national blog main
boston blog main
boston top stories
deals
national top stories
san francisco blog main
boston
ipo
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
vc
480 biomedical
acetylon pharmaceuticals
acute myeloid leukemia
adverum biotechnologies
ambit biosciences
ambys medicines
arsenal medical
athena countouriotis
azacitidine
beta-thalassemia
biotech investors
biotechnology
bob langer
brett zbar
bristol-myers squibb
cell therapy
chronic rhinosinusitis
clinical trials
constellation pharmaceuticals
cormorant asset management
covid-19
dacogen
daiichi sankyo
What
biotech
6
×
new
6
×
medical
startup
therapeutics
developing
medicines
million
raised
research
accomplish
aiming
aims
ambys
approach
astonishing
athena
attract
attracted
attractive
based
big
biotechnology
called
cancer
catching
ceo
chief
combinator’s
companies
company
control
countouriotis
country
day
days
deadly
deal
debut
debuted
Language
unset
Current search:
new
×
startups
×
photo
×
biotech
×
@tech.eu
2 years ago
Why biotech investors are attracted to Lithuania
@techcrunch.com
3 years ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?